NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit

A Novel Approach for Overcoming Drug Resistance in Breast Cancer Chemotherapy by Targeting new Synthetic Curcumin Analogues Against Aldehyde Dehydrogenase 1 (ALDH1A1) and Glycogen Synthase Kinase-3 β (GSK-3β)

(2015) Rajesh Kumar Kesharwani et al.   APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

ALDH1B1 links alcohol consumption and diabetes

(2015) Surendra Singh et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Aldehyde Dehydrogenase Is Regulated by  -Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells

(2015) M. Cojoc et al.   CANCER RESEARCH

Diverse Targets of  -Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse

(2015) Y.-W. Chang et al.   CANCER RESEARCH

Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways

(2015) Sergej Skvortsov et al.   SEMINARS IN CANCER BIOLOGY

Oxidored-nitro domain containing protein 1 (NOR1) expression suppresses slug/vimentin but not snail in nasopharyngeal carcinoma: Inhibition of EMT in vitro and in vivo in mice

(2014) Wei Wang et al.   CANCER LETTERS

β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids

(2014) S Condello et al.   ONCOGENE

Human ALDH1B1 Polymorphisms may Affect the Metabolism of Acetaldehyde and All-trans retinaldehyde—In Vitro Studies and Computational Modeling

(2014) Brian C. Jackson et al.   PHARMACEUTICAL RESEARCH

Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy

(2014) Pingpin Wei et al.   Stem Cell Research & Therapy

Cancer stem cells, a fuzzy evolving concept: A cell population or a cell property?

(2013) Aline Antoniou et al.   CELL CYCLE

Increased expression of aldehyde dehydrogenase 1 A1 in nasopharyngeal carcinoma is associated with enhanced invasiveness

(2013) Weijian Hou et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Tumor suppressor gene Oxidored-nitro domain-containing protein 1 regulates nasopharyngeal cancer cell autophagy, metabolism, and apoptosis in vitro

(2013) Wenjuan Li et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Identification of a subpopulation of nasopharyngeal carcinoma cells with cancer stem-like cell properties by high aldehyde dehydrogenase activity

(2013) Fenggang Yu et al.   LARYNGOSCOPE

Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma

(2012) Aibing Wu et al.   CANCER LETTERS

Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization

(2012) Virginia Tirino et al.   FASEB JOURNAL

Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress

(2012) Surendra Singh et al.   FREE RADICAL BIOLOGY AND MEDICINE

NOR1 Regulates Morphogenetic Cell Behavior in vitro Coincident With Inhibition of a Non-canonical Wnt-signaling Cascade*

(2012) Bo XIANG et al.   PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS

Frizzled and LRP5/6 Receptors for Wnt/ -Catenin Signaling

(2012) B. T. MacDonald et al.   Cold Spring Harbor Perspectives in Biology

Targeting cancer stem cells with ALDH1A1-based immunotherapy

(2012) Albert B. DeLeo   OncoImmunology

NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma

(2011) W. Li et al.   CARCINOGENESIS

Focus on Molecules: ALDH1A1: From lens and corneal crystallin to stem cell marker

(2011) Ying Chen et al.   EXPERIMENTAL EYE RESEARCH

Differential expression of oxidored nitro domain containing protein 1 (NOR1), in mouse tissues and in normal and cancerous human tissues

(2011) Bo Xiang et al.   GENE

Cells of origin in cancer

(2011) Jane E. Visvader   NATURE

Aberrant DNA Methylation Is Associated with Disease Progression, Resistance to Imatinib and Shortened Survival in Chronic Myelogenous Leukemia

(2011) Jaroslav Jelinek et al.   PLoS One

Wnt/β-catenin Signaling in Embryonic Stem Cell Self-renewal and Somatic Cell Reprogramming

(2011) Toshio Miki et al.   Stem Cell Reviews and Reports

Emerging Roles of Glycogen Synthase Kinase 3 in the Treatment of Brain Tumors

(2011) Caroline N. Mills et al.   Frontiers in Molecular Neuroscience

SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts

(2010) Elisabetta Lambertini et al.   BMC MOLECULAR BIOLOGY

Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?

(2010) F. Takahashi-Yanaga et al.   CLINICAL CANCER RESEARCH

Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways

(2010) Naoko Takebe et al.   Nature Reviews Clinical Oncology

LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy

(2010) C.-C. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Preparation of polyclonal antibody specific for NOR1 and detection of its expression pattern in human tissues and nasopharyngeal carcinoma

(2009) B. Xiang et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

The Emerging Role of EpCAM in Cancer and Stem Cell Signaling

(2009) M. Munz et al.   CANCER RESEARCH

Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse

(2008) H. Kroeger et al.   BLOOD

Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily

(2008) Satori A Marchitti et al.   Expert Opinion on Drug Metabolism & Toxicology

ALDH1 as a Functional Marker of Cancer Stem and Progenitor Cells

(2008) Julie Douville et al.   STEM CELLS AND DEVELOPMENT